Reaction

Growth Retardation reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,922 reports · 64 co-occurring drugs

As of the last recalculation, Growth Retardation appears in 2,922 FAERS reports alongside 64 co-occurring drug terms. The strongest observed disproportionality signal is CANAKINUMAB (PRR 58.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Canakinumab	86	58.3	58.8
Thiotepa	42	31.8	31.9
Methylphenidate Hydrochloride	232	30.2	30.3
Busulfan	63	29.1	29.2
Somatropin	246	26.0	26.0
Tofacitinib Citrate	40	22.0	22.1
Atomoxetine Hydrochloride	64	19.6	19.6
Imatinib	43	17.6	17.7
Anakinra	40	17.4	17.4
Asfotase Alfa	23	16.5	16.5
Alpelisib	18	14.8	14.8
Valproate Sodium	37	12.9	12.9
Fludarabine Phosphate	68	12.6	12.6
Alemtuzumab	32	11.9	11.9
Guanfacine	13	11.8	11.8
Zidovudine	22	11.8	11.8
Palivizumab	22	10.3	10.3
Phenobarbital	20	9.9	9.9
Colchicine	34	9.3	9.3
Itraconazole	15	9.2	9.2
Lisdexamfetamine Dimesylate	42	9.2	9.2
Adalimumab-Fkjp	56	8.8	8.8
Indomethacin	16	8.6	8.7
Adalimumab-Aaty	56	8.6	8.6
Misoprostol	11	8.1	8.1
Methylphenidate	32	7.9	8.0
Adalimumab-Adaz	56	7.7	7.7
Cyclosporine	114	7.6	7.6
Fluticasone Propionate Nasal	31	7.4	7.4
Tocilizumab	110	7.1	7.1
Mometasone	18	7.0	7.0
Mycophenolate Mofetil	120	6.5	6.5
Mycophenolate Mofetil Hydrochloride	120	6.5	6.5
Isotretinoin	44	6.4	6.4
Budesonide	52	6.4	6.4
Nevirapine	8	6.3	6.3
Imatinib Mesylate	23	5.9	5.9
Anastrozole Tablets	17	5.7	5.7
Melphalan	18	5.7	5.7
Melphalan Hydrochloride	19	5.4	5.4
Etoposide	54	5.3	5.3
Daspone	7	5.1	5.1
Dapsone Gel, 5%	7	5.1	5.1
Mesalamine	38	4.9	4.9
Cyclophosphamide Injection, Solution	116	4.8	4.8
Cyclophosphamide	116	4.8	4.8
Cyclophosphamide For Injection	116	4.8	4.8
Dapsone	7	4.7	4.7
Ifosfamide	14	4.7	4.7
Infliximab	136	4.6	4.6
Deferasirox	17	4.6	4.6
Anastrozole	23	4.5	4.5
Thalidomide	23	4.5	4.5
Dasatinib	23	4.4	4.4
Ritonavir 100 Mg	9	4.3	4.3
Oxcarbazepine	19	4.2	4.2
Ritonavir	17	4.2	4.2
Mometasone Furoate And Formoterol Fumarate Dihydrate	9	4.1	4.1
Sevoflurane	4	3.4	3.4
Vincristine Sulfate	14	3.4	3.4
Carboplatin	52	3.0	3.0
Vedolizumab	33	2.7	2.7
Bosutinib	3	2.4	2.4
Dornase Alfa	5	1.8	1.8

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.